TSHA – taysha gene therapies, inc. (US:NASDAQ)
Stock Stats
News
Taysha Gene Therapies Inc. (TSHA): A Promising Biotech on Rett Syndrome Drug Prospects [Yahoo! Finance]
Taysha Gene Therapies (NASDAQ:TSHA) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
Taysha Gene Therapies (NASDAQ:TSHA) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $12.00 price target on the stock.
Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome
Taysha Gene Therapies (NASDAQ:TSHA) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Form 4 Taysha Gene Therapies, For: Jan 12 Filed by: Nolan Sean P.
Form 4 Taysha Gene Therapies, For: Jan 12 Filed by: Nagendran Sukumar
Form 4 Taysha Gene Therapies, For: Jan 12 Filed by: Alam Kamran
Form 144 Taysha Gene Therapies, Filed by: Nagendran Sukumar
Form S-8 Taysha Gene Therapies,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.